Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,391,769
+$77,896 QoQ
Shares Held
13,355
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1,909
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SITTNER & NELSON, LLC holds $15,187,262 across 14 Drug Manufacturers - General names. JNJ ranks #1 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
13,355 | $3,391,769 | |
| 2 | AMGN |
Amgen Inc
|
7,136 | $2,584,088 | |
| 3 | LLY |
ELI LILLY & Co
|
1,120 | $1,343,361 | |
| 4 | NVS |
Novartis AG
|
8,339 | $1,306,888 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,398 | $1,232,952 | |
| 6 | PFE |
Pfizer Inc
|
43,693 | $1,052,127 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,165 | $1,049,202 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,100 | $1,023,354 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,391,769 | 13,355 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,313,873 | 13,557 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,842,458 | 13,735 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,525,420 | 13,620 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,110,241 | 13,815 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,295,059 | 13,839 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,025,692 | 14,007 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,241,127 | 13,829 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,053,255 | 14,048 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,286,952 | 14,457 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,291,225 | 14,618 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,527,822 | 16,230 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,755,908 | 16,650 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,604,775 | 16,805 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,887,697 | 16,347 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,685,475 | 16,439 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,924,832 | 16,477 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,710,023 | 15,291 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,602,658 | 15,214 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,359,676 | 14,611 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,411,464 | 14,638 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,380,609 | 14,485 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,090,793 | 13,285 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||